Temporin-PE

General Information


DRACP ID  DRACP00806

Peptide Name   Temporin-PE

Sequence  FLPIVAKLLSGLL

Sequence Length  13

UniProt ID  A0A2H4WAJ8 

PubChem CID  Not available

Origin  Pelophylax kl.esculentus(Europe edible frog)

Type  Native peptide

Classification

  

Active ACP Membrane-targeted



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
NCI-H157 Lung squamous cell carcinoma Carcinoma IC50=34.56µM MTT assay Not available 1
U-251MG Astrocytoma Carcinoma IC50=25.13µM MTT assay Not available 1
PC-3 Prostate carcinoma Carcinoma IC50=38.56µM MTT assay Not available 1
MDA-MB-435s Amelanotic melanoma Carcinoma IC50=33.23µM MTT assay Not available 1

Hemolytic Activity  Horse erythrocytes(HD50=39.64μM)

Normal (non-cancerous) Cytotoxicity  HMEC-1: IC50=58.62µM

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antimicrobial; Antibacterial; Anitifungal



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00806

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Not available

C-terminal Modification  Not available

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C69H118N14O15

Absent amino acids  CDEHMNQRTWY

Common amino acids  L

Mass  159802

Pl  9.7

Basic residues  1

Acidic residues  0

Hydrophobic residues  9

Net charge  1

Boman Index  3034

Hydrophobicity  196.92

Aliphatic Index  210

Half Life 
  Mammalian: 4.4 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  2

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 29191658

Title  Identification and target-modifications of temporin-PE: A novel antimicrobial peptide in the defensive skin secretions of the edible frog, Pelophylax kl. Esculentus

Doi 10.1016/j.bbrc.2017.11.173

Year  2017

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.